Overview: China copes with dissent over lockdowns, plus research and other developments

Primary tabs

Overview: China copes with dissent over lockdowns, plus research and other developments

The COVID-19 restrictions are at the heart of the unrest in China as the country grapples with a rising number of infections after years of quarantine policies. 

CNN reports there is “a growing torrent of dissent toward China’s unrelenting zero-Covid lockdowns.” A fatal fire in an apartment building in Xinjiang has raised further questions, with residents in that city restricted to their homes for more than three months, according to the New York Times. An estimated one-fifth of the country is under restrictions, and more than 1.3 million people in China are under medical observation this week after being exposed to the virus, the Financial Times reported.

China’s zero-COVID policy aims to do just that: eradicate the spread of the virus. But in the three years since the first infections were reported in China, the country is now facing a record number of cases

Other COVID news to know: 

  • Researchers at Stanford Medicine in Palo Alto, Calif., are studying Pfizer’s PFE, 0.27% antiviral Paxlovid to see if it can treat long COVID, the constellation of lingering symptoms that can occur after an infection, according to NBC News. There are currently no treatments for long COVID. 
  • ...
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 0.407 seconds.